Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

913 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Limitations of extensive TPMT genotyping in the management of azathioprine-induced myelosuppression in IBD patients.
Dewit O, Moreels T, Baert F, Peeters H, Reenaers C, de Vos M, Van Hootegem P, Muls V, Veereman G, Mana F, Van Outryve M, Holvoet J, Naegels S, Piessevaux H, Horsmans Y, Gala JL; Belgian Inflammatory Bowel Disease Research Group (BIRD). Dewit O, et al. Among authors: de vos m. Clin Biochem. 2011 Sep;44(13):1062-1066. doi: 10.1016/j.clinbiochem.2011.06.079. Epub 2011 Jun 24. Clin Biochem. 2011. PMID: 21723857
Acute lower gastrointestinal bleeding in Crohn's disease: characteristics of a unique series of 34 patients. Belgian IBD Research Group.
Belaiche J, Louis E, D'Haens G, Cabooter M, Naegels S, De Vos M, Fontaine F, Schurmans P, Baert F, De Reuck M, Fiasse R, Holvoet J, Schmit A, Van Outryve M. Belaiche J, et al. Among authors: de vos m, de reuck m. Am J Gastroenterol. 1999 Aug;94(8):2177-81. doi: 10.1111/j.1572-0241.1999.01291.x. Am J Gastroenterol. 1999. PMID: 10445546
Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia.
Cremer A, Demetter P, De Vos M, Rahier JF, Baert F, Moreels T, Macken E, Louis E, Ferdinande L, Fervaille C, Dedeurwaerdere F, Bletard N, Driessen A, De Hertogh G, Vermeire S, Franchimont D; Belgian Inflammatory Bowel Disease Research and Development (BIRD) Group. Cremer A, et al. Among authors: de vos m, de hertogh g. Clin Gastroenterol Hepatol. 2020 Jun;18(7):1528-1536.e5. doi: 10.1016/j.cgh.2019.05.062. Epub 2019 Jun 13. Clin Gastroenterol Hepatol. 2020. PMID: 31202983 Free article.
Long-term Outcomes with Anti-TNF Therapy and Accelerated Step-up in the Prospective Pediatric Belgian Crohn's Disease Registry (BELCRO).
Wauters L, Smets F, De Greef E, Bontems P, Hoffman I, Hauser B, Alliet P, Arts W, Peeters H, Van Biervliet S, Paquot I, Van de Vijver E, De Vos M, Bossuyt P, Rahier JF, Dewit O, Moreels T, Franchimont D, Muls V, Fontaine F, Louis E, Coche JC, Baert F, Paul J, Vermeire S, Veereman G. Wauters L, et al. Among authors: de vos m, de greef e. Inflamm Bowel Dis. 2017 Sep;23(9):1584-1591. doi: 10.1097/MIB.0000000000001193. Inflamm Bowel Dis. 2017. PMID: 28696956 Free article.
Ulcerative colitis treatment : an insight into daily clinical practice.
Bossuyt P, Baert F, Coenegrachts JL, De Vos M, Dewit O, Ferrante M, Fontaine F, Mana F, Vandervoort J, Moreels T. Bossuyt P, et al. Among authors: de vos m. Acta Gastroenterol Belg. 2019 Jul-Sep;82(3):365-372. Acta Gastroenterol Belg. 2019. PMID: 31566323 Free article.
Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists.
De Vos M, Dhooghe B, Vermeire S, Louis E, Mana F, Elewaut A, Bossuyt P, Baert F, Reenaers C, Van Gossum M, Macken E, Ferrante M, Hindryckx P, Dewit O, Holvoet T, Franchimont D; Belgian Inflammatory Bowel Disease Research and Development (BIRD). De Vos M, et al. United European Gastroenterol J. 2018 Apr;6(3):439-445. doi: 10.1177/2050640617722310. Epub 2017 Jul 26. United European Gastroenterol J. 2018. PMID: 29774158 Free PMC article.
913 results